FDA Studying Safety of Arthritis Drugs
482024
Vioxx and other pain-relieving drugs have given many people with chronic pain the chance to resume normal lives. But an increase in heart attacks among users of the popular arthritis drug led the manufacturer to pull it from the market and has cast a shadow over similar medications.
538035
Users of an anti-arthritis drug linked by a study to an increased risk of heart attacks and strokes have been urged not to panic. The UK Department of Health said users of Celebrex, manufactured by US drug
145921
With the stunning recall of a popular pain medication last week and the impact it had on patients, the stock market and its manufacturer, it may be worthwhile to review how drugs get to market and how safety data are gathered.
573622
FRIDAY, Oct. 8 (HealthDayNews) -- A week after drug giant Merck & Co. withdrew its arthritis drug Vioxx from the market, doubts are being raised about the safety of the two other approved medications in this class, Bextra and Celebrex.
742151
The safety of Celebrex and other pain relievers was questioned Wednesday as scientists in the United States and regulatory agencies in Europe said they feared such drugs might raise the same risk of heart problems as those blamed on the arthritis medicine Vioxx.    One key researcher charged the U.S...
411659
Millions of people who take Celebrex to treat arthritis have been left with a difficult decision to make after a study showed Celebrex increases the risk of heart attacks and strokes when taken in large doses.
462742
People who use the drug Remicade for rheumatoid arthritis may be at increased risk of a serious blood disorder, the US Food and Drug Administration warned.
303248
Users of an anti-arthritis drug have been warned that it could cause an increased risk of heart attacks and strokes. A new study linked the drug to the health risks, but users of Celebrex (celecoxib), manufactured
230283
With Vioxx off the market because of links to heart problems and concerns growing about the related drugs Celebrex and Bextra, a pair of Food and Drug Administration advisory committees are assessing the safety of the popular painkillers.
232811
The US Food and Drug Administration today announced a five-step program to bolster drug safety evaluations. The news comes after controversy over the recall of the arthritis drug Vioxx and risks to children on antidepressants.
109195
Medicines used by millions of  Americans to relieve aches and pains will come under intense  scrutiny starting Wednesday as U.S. scientists scour dozens of  studies to determine if the drugs risk damaging the heart like  Merck & Co. Inc.'s withdrawn arthritis pill Vioxx.
238122
The Food and Drug Administration yesterday called for an evaluation of all prevention studies involving two controversial painkillers - Celebrex and Bextra - to ensure adequate protection for participants who use the pills.
80442
The US Food and Drug Administration on Thursday ordered the review of preventative studies involving Pfizer Inc.&#39;s painkillers Celebrex and Bextra, in light of recent evidence they may increase the risk of heart attack and stroke.
144122
Scientists uncover why some arthritis drugs such as Vioxx can cause heart attacks and strokes.
34608
GAITHERSBURG, Md.  - U.S. scientific advisers  began hearing evidence on Wednesday about the benefits and  risks of pain killers taken by millions of Americans as  regulators weigh moves following Merck & Co. Inc.'s recall of  its arthritis pill Vioxx.
131494
(Undated) Oct. 19, 2004 - The maker of arthritis drug Celebrex is launching a study to see if the drug has the same dangerous side effects that took Vioxx off the market.
159888
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way it monitors safety risks associated with medicines already  on the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.